Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3291811

THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    2.5.2016
  • EP published:
    7.8.2019
  • EP application number:
    16719430.7
  • Max expiry date:
    1.5.2036
  • Title:
    THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)

Timeline

Today
2.5.2016EP application
7.8.2019EP Publication

Owner

  • Name:
    Bayer Pharma Aktiengesellschaft
  • Address:
    Müllerstrasse 178, 13353, Berlin, DE

Inventor

  • Name:
    HIRTH-DIETRICH, Claudia
  • Address:
    Wuppertal, DE
  • Name:
    SANDNER, Peter
  • Address:
    Wuppertal, DE
  • Name:
    STASCH, Johannes-Peter
  • Address:
    Grottaferrata, IT
  • Name:
    HAHN, Michael
  • Address:
    Langenfeld, DE
  • Name:
    FOLLMANN, Markus
  • Address:
    Köln, DE
  • Name:
    VAKALOPOULOS, Alexandros
  • Address:
    Hilden, DE

Priority

  • Number:
    15166516
  • Date:
    6.5.2015
  • Country:
    EP

Classification

  • Categories:
    A61K 31/426, A61K 31/427, A61K 31/4439, A61K 31/506, A61K 31/519, A61K 31/5377, A61K 31/635, A61K 45/06, A61P 17/02, A61K 31/197, A61K 31/53

Upload documents